Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747576 · ClinicalTrials.gov registry record
Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 137
- Enrollment target
NCT02747576 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 137 participants.
The verdict
NCT02747576 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 137 participants
- Enrollment target
Study Summary
Survivors of pediatric medulloblastoma (MB) are at-risk for neurocognitive and social deficits, including specific skills such as facial affect recognition which is the ability to recognize the emotional expressions of another person. Because the underlying mechanisms of these deficits are poorly understood, the investigators propose to examine social-cognitive skills (i.e. facial affect recognition) and indices of brain integrity, including an established core neural network of face perception in MB survivors and healthy controls. By comparing these outcomes between survivors of MB and healthy controls, investigators seek to identify the areas of the brain that help individuals recognize emotions. Primary Objective: * To evaluate social cognition in adolescent and young adult survivors of pediatric medulloblastoma. Secondary Objective: * To examine indices of brain integrity and function and their association with facial affect recognition in survivors of pediatric medulloblastoma.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2016-07-13 |
| Est. Completion | 2018-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02747576
The ClinicalTrials.gov registry entry for NCT02747576 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02747576 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02747576 about?
NCT02747576 is a clinical study titled "Social Cognition and Brain Integrity in Survivors of Pediatric Medulloblastoma". Survivors of pediatric medulloblastoma (MB) are at-risk for neurocognitive and social deficits, including specific skills such as facial affect recognition which is the ability to recognize the emotional expressions of another person. Because the underlying mechanisms of these deficits are poorly un...
What is the current status of trial NCT02747576?
This trial is currently completed. The enrollment target is 137 participants. The study started on 2016-07-13. Estimated completion is 2018-08-31.
Who is sponsoring clinical trial NCT02747576?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.